PHILADELPHIA, May 21, 2020 /PRNewswire/ — Carisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present and take meetings at upcoming virtual healthcare investor conferences in May and June 2020.Click here for more information.
Read MoreCarisma Therapeutics expands on foundational first-of-its-kind engineered macrophage cell therapy platform study and explores time-reducing isolation-to-infusion pathway. For full press release, click here
Read MoreStudy highlights previously untapped potential of genetically engineered macrophages in immunotherapy for solid tumors. For full press release, click here.
Read MoreCarisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at two conferences in March, 2020. For full press release, click here.
Read MoreCarisma Therapeutics expands leadership with appointments of Debora Barton, MD as Chief Medical Officer, and Tom Wilton as Chief Business Officer. For full press release, see here.
Read More